\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\	lower\\ extremities\\ demonstrated\\ multiple\\ pink\\,\\ somewhat\\	translucent\\,\\ 1\\-2\\ cm\\ nodules\\ coalescing\\ into\\ plaques\\ on\\ both\\ ankles\\ and\\ pretibial\\ areas\\.\\ \ \(0\)\
\-\ histopathology\\:\\ sections\\ demonstrated\\ marked\\ mucin\\ deposition\\ in\\ the\\ upper\\ half\\ of\\ the\\ dermis\\ replacing\\ the\\ dermal\\ collagen\\.\ \(0\)\
\-\ lesions\\ have\\ remained\\ stable\\ with\\ no\\ changes\\.\\ topical\\ high\\ potency\\ steroids\\ had\\ no\\ effect\\.\\ he\\ refused\\ a\\ trial\\ of\\ intralesional\\ steroid\\ injections\\.\ \(0\)\
\-\ nodular\\ pretibial\\ myxedema\\ \\(1997\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ case\\#22\\)\\ presented\\ by\\:\\ joseph\\ l\\.\\ wilde\\,\\ cpt\\,\\ mc\\,\\ usa\ \(0\)\
\-\ 63\\ year\\ old\\ white\\ male\\ presented\\ with\\ a\\ six\\ month\\ history\\ of\\ asymptomatic\\ lower\\ extremity\\ nodules\\.\\ past\\ medical\\ history\\ was\\ significant\\ for\\ longstanding\\ diabetes\\ mellitus\\ and\\ hyperthyroidism\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pretibial\\:\\ 0\\.30511701252124046\ \(0\)\
\-\ wilde\\:\\ 0\\.1768438374396351\ \(0\)\
\-\ nodules\\:\\ 0\\.17572736441959566\ \(0\)\
\-\ translucent\\:\\ 0\\.16898372768258474\ \(0\)\
\-\ coalescing\\:\\ 0\\.16898372768258474\ \(0\)\
\-\ potency\\:\\ 0\\.16340689105869574\ \(0\)\
\-\ myxedema\\:\\ 0\\.16340689105869574\ \(0\)\
\-\ cpt\\:\\ 0\\.15255850626062023\ \(0\)\
\-\ refused\\:\\ 0\\.14564421412823694\ \(0\)\
\-\ intralesional\\:\\ 0\\.14055817374201424\ \(0\)\
\-\ mucin\\:\\ 0\\.136532998296817\ \(0\)\
\-\ demonstrated\\:\\ 0\\.13592078729736623\ \(0\)\
\-\ replacing\\:\\ 0\\.1353577647886116\ \(0\)\
\-\ usa\\:\\ 0\\.13320160959231592\ \(0\)\
\-\ ankles\\:\\ 0\\.1312614501226305\ \(0\)\
\-\ topical\\:\\ 0\\.1312614501226305\ \(0\)\
\-\ dermal\\:\\ 0\\.1294979243661792\ \(0\)\
\-\ presented\\:\\ 0\\.12896969462304983\ \(0\)\
\-\ sections\\:\\ 0\\.12867288853976663\ \(0\)\
\-\ longstanding\\:\\ 0\\.12867288853976663\ \(0\)\
\-\ pink\\:\\ 0\\.12638961540660526\ \(0\)\
\-\ dermis\\:\\ 0\\.12500435366942284\ \(0\)\
\-\ hyperthyroidism\\:\\ 0\\.12434715799024719\ \(0\)\
\-\ trial\\:\\ 0\\.12309605191587765\ \(0\)\
\-\ mellitus\\:\\ 0\\.12309605191587765\ \(0\)\
\-\ injections\\:\\ 0\\.12192081840767223\ \(0\)\
\-\ mc\\:\\ 0\\.11606097798523984\ \(0\)\
\-\ lower\\:\\ 0\\.11301449965142354\ \(0\)\
\-\ collagen\\:\\ 0\\.11224766711780214\ \(0\)\
\-\ plaques\\:\\ 0\\.11156740728848347\ \(0\)\
\-\ histopathology\\:\\ 0\\.11156740728848347\ \(0\)\
\-\ deposition\\:\\ 0\\.11156740728848347\ \(0\)\
\-\ seminar\\:\\ 0\\.11123602458809377\ \(0\)\
\-\ uniformed\\:\\ 0\\.11027456725631904\ \(0\)\
\-\ remained\\:\\ 0\\.10935855043061607\ \(0\)\
\-\ 1997\\:\\ 0\\.10935855043061607\ \(0\)\
\-\ services\\:\\ 0\\.10848387202673286\ \(0\)\
\-\ dermatology\\:\\ 0\\.10820086822818946\ \(0\)\
\-\ 63\\:\\ 0\\.1068446918916748\ \(0\)\
\-\ steroid\\:\\ 0\\.10658448105978838\ \(0\)\
\-\ joseph\\:\\ 0\\.10461972080519166\ \(0\)\
\-\ half\\:\\ 0\\.10415814147721342\ \(0\)\
\-\ diabetes\\:\\ 0\\.1010076444358994\ \(0\)\
\-\ somewhat\\:\\ 0\\.10062376226968248\ \(0\)\
\-\ six\\:\\ 0\\.0993370539522326\ \(0\)\
\-\ steroids\\:\\ 0\\.09715283783536753\ \(0\)\
\-\ nodular\\:\\ 0\\.08806149429262632\ \(0\)\
\-\ stable\\:\\ 0\\.08747401248840775\ \(0\)\
\-\ 22\\:\\ 0\\.0870920214900289\ \(0\)\
\-\ history\\:\\ 0\\.08449704313968368\ \(0\)\
\-\ extremities\\:\\ 0\\.0840363188474291\ \(0\)\
\-\ marked\\:\\ 0\\.08363660538926783\ \(0\)\
\-\ extremity\\:\\ 0\\.07964607770290705\ \(0\)\
\-\ effect\\:\\ 0\\.07757144531499932\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.07528174359086261\ \(0\)\
\-\ areas\\:\\ 0\\.07507714627313512\ \(0\)\
\-\ white\\:\\ 0\\.07295851816581524\ \(0\)\
\-\ past\\:\\ 0\\.0719801473581693\ \(0\)\
\-\ no\\:\\ 0\\.07191966879157835\ \(0\)\
\-\ medical\\:\\ 0\\.0702789450734888\ \(0\)\
\-\ month\\:\\ 0\\.06726798376198864\ \(0\)\
\-\ changes\\:\\ 0\\.0668308266301673\ \(0\)\
\-\ the\\:\\ 0\\.06619502791868966\ \(0\)\
\-\ he\\:\\ 0\\.06548229057498177\ \(0\)\
\-\ of\\:\\ 0\\.06492091018966788\ \(0\)\
\-\ significant\\:\\ 0\\.06384730233439533\ \(0\)\
\-\ cm\\:\\ 0\\.06350819020172281\ \(0\)\
\-\ lesions\\:\\ 0\\.06350819020172281\ \(0\)\
\-\ high\\:\\ 0\\.06284725973476787\ \(0\)\
\-\ both\\:\\ 0\\.06166565677820272\ \(0\)\
\-\ physical\\:\\ 0\\.059959809248614965\ \(0\)\
\-\ upper\\:\\ 0\\.05909302274196527\ \(0\)\
\-\ into\\:\\ 0\\.0587832035644466\ \(0\)\
\-\ exam\\:\\ 0\\.055666765184344005\ \(0\)\
\-\ case\\:\\ 0\\.05555492593620481\ \(0\)\
\-\ have\\:\\ 0\\.055241507725046025\ \(0\)\
\-\ had\\:\\ 0\\.05509575203155401\ \(0\)\
\-\ multiple\\:\\ 0\\.05408780161040046\ \(0\)\
\-\ male\\:\\ 0\\.04923512244525054\ \(0\)\
\-\ by\\:\\ 0\\.04695930380781971\ \(0\)\
\-\ and\\:\\ 0\\.045700612119604266\ \(0\)\
\-\ with\\:\\ 0\\.0433064669453576\ \(0\)\
\-\ was\\:\\ 0\\.0385387356326573\ \(0\)\
\-\ year\\:\\ 0\\.03407903059079289\ \(0\)\
\-\ for\\:\\ 0\\.03351639360098853\ \(0\)\
\-\ on\\:\\ 0\\.0333975007664369\ \(0\)\
\-\ old\\:\\ 0\\.032727666116355095\ \(0\)\
\-\ in\\:\\ 0\\.02750907986284725\ \(0\)\
